dr. camidge on ap26113 in patients with advanced malignancies
Published 10 years ago • 299 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
9:36
dr. d ross camidge on teliso-v monotherapy in patients with previously treated c-met advanced nsclc
-
1:37
dr. camidge on the alex trial in patients with alk nsclc
-
1:34
dr. camidge on the alta study of brigatinib in nsclc
-
1:00
dr. camidge on phase i study with azd9291 in nsclc
-
1:55
dr. d. ross camidge on targeted therapies in adjuvant non-small cell lung cancer
-
3:58
diagnosis and detection of stomach cancer
-
4:39
phase 1 clinical trial for anaplastic large cell lymphoma: zach witt's story
-
1:22
doctors confused: lung nodules disappear with gut health approach
-
1:51
dr. camidge discusses treatment of patients with alk nsclc
-
1:19
dr. ross camidge discusses resequencing lung cancer
-
1:09
dr. camidge on crizotinib as a ros1 inhibitor in nsclc
-
1:52
dr. camidge on optimal therapy in egfr nsclc
-
6:19
ross camidge: brigatinib for adult patients with alk metastatic non-small cell lung cancer
-
5:53
next-generation alk inhibitors in non-small cell lung cancer
-
1:28
dr. camidge on met as a target in lung cancer
-
1:27
dr. camidge on the keynote-024 trial in nsclc
-
1:00
dr. camidge discusses unmet needs in alk lung cancer
-
3:21
phase 1 study of crizotinib in patients with alk-positive non-small cell lung cancer
-
1:29
dr. camidge on the unmet needs for lung cancer
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
0:59
sym015: met antibody mixture for advanced solid tumors
-
0:57
dr. choti discusses immunotherapy in pancreatic cancer